How ‘people power’ and business transformed medicine, but created a whole new set of risks
(Version anglaise seulement)
par Christine Mary Hallinan, Senior Research Fellow, Department of General Practice and Primary Care, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne
We’re seeing what happens when consumer demand collides with commercial interests for drugs including GLP-1s, psychedelics and testosterone. It’s a huge shift.
Lire l'article complet
© La Conversation
-
dimanche 11 octobre 2026
